In this issue of Blood, Poli et al demonstrate that heparin analogs engineered to minimize their anticoagulant properties can potently downregulate hepcidin production in vitro and in vivo, and may potentially be used to treat the anemia of inflammation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945857 | PMC |
| http://dx.doi.org/10.1182/blood-2014-01-549519 | DOI Listing |
Publication Analysis
Top Keywords
bumping iron
4
iron modified
4
modified heparins
4
heparins issue
4
issue blood
4
blood poli
4
poli demonstrate
4
demonstrate heparin
4
heparin analogs
4
analogs engineered
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!